Resolute Advisors LLC 4 D Molecular Therapeutics, Inc. Transaction History

Resolute Advisors LLC

  • $539 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$13.16 - $22.64 $276 - $475
-21 Reduced 0.22%
9,600 $145,000
Q2 2021

Aug 13, 2021
BUY
$22.2 - $42.29 $466 - $888
21 Added 0.22%
9,621 $231,000
Q1 2021

May 17, 2021
BUY
$35.94 - $52.67 $345,024 - $505,632
9,600 New
9,600 $416,000

Others Institutions Holding FDMT

# of Institutions
157
Shares Held
50.3M
Call Options Held
718K
Put Options Held
370K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $675M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Resolute Advisors LLC Portfolio

Follow Resolute Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email